Viking Global Investors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.6M | Sell |
|
|||||
|
2025
Q1 | $329M | Sell |
|
|||||
|
2024
Q4 | $311M | Buy |
|
|||||
|
2024
Q3 | $342M | Buy |
|
|||||
|
2024
Q2 | $316M | Buy |
|
|||||
|
2024
Q1 | $349M | Buy |
|
|||||
|
2023
Q4 | $283M | Buy |
|
|||||
|
2023
Q3 | $257M | Sell |
|
|||||
|
2023
Q2 | $303M | Sell |
|
|||||
|
2023
Q1 | $404M | Buy |
|
|||||
|
2022
Q4 | $396M | Sell |
|
|||||
|
2022
Q3 | $437M | Sell |
|
|||||
|
2022
Q2 | $520M | Buy |
|
|||||
|
2022
Q1 | $419M | Buy |
|
|||||
|
2021
Q4 | $411M | Buy |
|
|||||
|
2021
Q3 | $150M | Buy |
|
|||||
|
2021
Q2 | $133M | Buy |
|
|||||
|
2021
Q1 | $89.9M | Sell |
|
|||||
|
2020
Q4 | $114M | Buy |
|
|||||
|
2020
Q3 | $82M | Sell |
|
|||||
|
2020
Q2 | $122M | Buy |
|